Skip to content
Inciteful Med

Symptoms & Misdiagnoses of Fabry Disease

Last updated:

Fabry disease is a genetic condition causing burning hand and foot pain, reduced sweating, GI issues, and progressive heart or kidney damage. Because symptoms mimic common issues like growing pains or IBS, it is frequently misdiagnosed. Genetic testing is crucial for an accurate diagnosis.

Key Takeaways

  • • Classic Fabry disease symptoms typically begin before age 10 and include severe hand and foot pain, reduced sweating, and gastrointestinal issues.
  • • Late-onset Fabry disease often appears in adulthood and primarily affects the heart or kidneys, leading to conditions like left ventricular hypertrophy.
  • • Fabry disease is frequently misdiagnosed as growing pains, IBS, or multiple sclerosis because its symptoms overlap with many common conditions.
  • • Females are not just carriers of Fabry disease and can experience symptoms ranging from mild to severe.
  • • Standard enzyme blood tests can sometimes appear normal in females with Fabry disease, making genetic testing essential for a confirmed diagnosis.

Understanding the symptoms of Fabry disease is often like putting together a complex puzzle. Because the disease affects so many different parts of the body, symptoms can seem unrelated, leading many people to spend years—or even decades—searching for the right diagnosis [1][2].

Early Warning Signs in Children (Classic Fabry)

In the “classic” form of the disease, symptoms usually begin in childhood, often before the age of 10 [3][4]. These early signs are frequently misunderstood:

  • Neuropathic Pain (Acroparesthesia): This is the most common early symptom, affecting 60% to 80% of children [3][5]. It feels like a burning, tingling, or “pins and needles” sensation in the hands and feet [6][4]. These pain crises can be triggered by fatigue, stress, exercise, or changes in temperature [3][7].
  • Gastrointestinal (GI) Issues: Many children experience frequent abdominal pain, bloating, or diarrhea, especially after eating [3][5].
  • Hypohidrosis (Reduced Sweating): Children with Fabry often sweat very little or not at all [4][8]. This can lead to overheating and a strong dislike of physical activity or hot weather [9].
  • Cornea Verticillata: This is a distinctive, whorl-like pattern on the cornea (the clear front of the eye) [10]. It does not affect vision but is a critical diagnostic “red flag” for doctors [4].
  • Angiokeratomas: These are small, dark red or purple skin spots that usually appear in the “bathing suit” area (hips, groin, and lower abdomen), but they can also occasionally be seen on the lips or inside the mouth [11].

Late-Onset Symptoms in Adults

Some people have a “non-classic” or late-onset version of the disease. In these cases, early childhood symptoms may be mild or absent, with major signs not appearing until the 30s, 40s, or even 70s [12][13]. These symptoms usually focus on one or two major organs:

  • Heart Involvement: The most common sign is Left Ventricular Hypertrophy (LVH), which is a thickening of the heart muscle [14][15]. This can lead to heart failure, irregular heartbeats (like atrial fibrillation), or fainting [15][16].
  • Kidney Disease: Without intervention, Fabry can cause the kidneys to stop filtering waste correctly, which is why treatments are specifically designed to prevent End-Stage Renal Disease (ESRD) [16][17].
  • Stroke: Adults with unmanaged Fabry are at a higher risk for early-onset stroke, making proactive care essential [18][19].

Why Misdiagnosis is Common

Because Fabry symptoms overlap with so many other conditions, it is frequently misidentified. This “diagnostic odyssey” can be frustrating and exhausting [20].

Common Misdiagnosis Why it Happens in Fabry Disease
Growing Pains The intense hand and foot pain in children is often dismissed as normal childhood “growing pains” [4].
IBS (Irritable Bowel Syndrome) The frequent stomach pain and diarrhea are very similar to IBS symptoms [4][21].
Hypertrophic Cardiomyopathy (HCM) The thickening of the heart in late-onset Fabry looks almost identical to standard HCM on an ultrasound [22][23].
Multiple Sclerosis (MS) Because Fabry affects the nervous system and can show up as white spots on a brain MRI, it is sometimes mistaken for MS [24].
Rheumatism/Arthritis The joint-like pain and fatigue can lead doctors to suspect autoimmune or inflammatory conditions [3].

Differences Between Males and Females

While males typically show more severe and earlier symptoms, females are not just “carriers.” Due to a process called X-chromosome inactivation, females have a “mosaic” of cells—some with the working gene and some with the Fabry gene [25][26]. This means a woman’s symptoms can range from very mild to just as severe as a male’s [26][27]. It also means that standard blood tests for enzyme levels can sometimes come back “normal” in females even if they have the disease, making genetic testing essential [27].

Frequently Asked Questions

What are the early warning signs of classic Fabry disease in children?
Classic Fabry disease usually begins before age 10 with symptoms like burning or tingling pain in the hands and feet. Children may also experience frequent stomach pain, an inability to sweat normally, and small dark red spots on the skin.
Why is Fabry disease often misdiagnosed?
Fabry disease affects many different parts of the body, so its symptoms often overlap with other conditions. For example, severe hand and foot pain in children is frequently dismissed as growing pains, while stomach issues are often mistaken for irritable bowel syndrome (IBS).
What are the symptoms of late-onset Fabry disease in adults?
Late-onset Fabry disease often presents in adulthood with major issues focused on the heart or kidneys. The most common sign is a thickening of the heart muscle, known as left ventricular hypertrophy, which can lead to heart failure, irregular heartbeats, or early-onset stroke.
Can females get Fabry disease, or are they just carriers?
Females are not just carriers and can experience the full range of Fabry disease symptoms, from very mild to severe. Because females have a mix of working and non-working genes, their symptoms and severity can vary significantly.
Why is a normal enzyme test not always enough to rule out Fabry disease in females?
Because females have a mosaic of cells—some with the working gene and some with the Fabry gene—standard blood tests for enzyme levels can sometimes appear normal even if they have the disease. Genetic testing is essential for an accurate diagnosis in females.

Questions for Your Doctor

  • • Could my/my child's history of 'growing pains' or 'IBS' actually have been early neuropathic pain and GI issues related to Fabry disease?
  • • Does my/my child's lack of sweating (hypohidrosis) or heat intolerance fit the classic Fabry profile?
  • • I've heard about 'cornea verticillata' (whorl-like patterns in the eye)—can an eye exam help confirm a Fabry diagnosis?
  • • If I have heart thickening (LVH), how can we tell if it's from Fabry disease or standard hypertrophic cardiomyopathy?
  • • Since I am female, is it possible for my enzyme levels to be normal even if I have symptoms? Should we prioritize genetic testing?

Questions for You

  • • Did I experience intense, burning pain in my hands or feet as a child, especially during a fever or exercise?
  • • Do I often feel overheated or notice that I don't sweat as much as other people do?
  • • Have I been diagnosed with multiple conditions (like IBS, heart thickening, or kidney issues) that no one has connected into one single diagnosis before?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Anderson-Fabry disease in heart failure.

    Akhtar MM, Elliott PM

    Biophysical reviews 2018; (10(4)):1107-1119 doi:10.1007/s12551-018-0432-5.

    PMID: 29909504
  2. 2

    Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review.

    Caputo F, Lungaro L, Galdi A, et al.

    International journal of environmental research and public health 2021; (18(6)) doi:10.3390/ijerph18063320.

    PMID: 33807115
  3. 3

    [Guidelines for diagnosis, therapy and follow up of Anderson-Fabry disease].

    Kes VB, Cesarik M, Zavoreo I, et al.

    Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 2014; (68(2)):223-32.

    PMID: 26012164
  4. 4

    Treatment of Anderson-Fabry Disease.

    Simonetta I, Tuttolomondo A, Daidone M, et al.

    Current pharmaceutical design 2020; (26(40)):5089-5099 doi:10.2174/1381612826666200317142412.

    PMID: 32183665
  5. 5

    Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson-Fabry Disease.

    Tuttolomondo A, Baglio I, Riolo R, et al.

    International journal of molecular sciences 2023; (25(1)) doi:10.3390/ijms25010061.

    PMID: 38203231
  6. 6

    Fabry disease in children: a federal screening programme in Russia.

    Namazova-Baranova LS, Baranov AA, Pushkov AA, Savostyanov KV

    European journal of pediatrics 2017; (176(10)):1385-1391 doi:10.1007/s00431-017-2992-y.

    PMID: 28871487
  7. 7

    Restoration of peripheral neuropathy in Fabry mice via intrathecal administration of an adeno-associated virus vector encoding mGLA cDNA.

    Higuchi T, Shimada Y, Takahashi Y, et al.

    Molecular genetics and metabolism 2024; (143(1-2)):108545 doi:10.1016/j.ymgme.2024.108545.

    PMID: 39068683
  8. 8

    New mutation in Fabry disease: c.448delG, first phenotypic description.

    Calabrese E, Rodriguez Botta G, Rosenfeld DP

    Molecular genetics and metabolism reports 2021; (27()):100708 doi:10.1016/j.ymgmr.2021.100708.

    PMID: 33732617
  9. 9

    Cardiopulmonary determinants of reduced exercise tolerance in Fabry disease.

    De Marco O, Gambardella J, Bianco A, et al.

    Frontiers in cardiovascular medicine 2024; (11()):1396996 doi:10.3389/fcvm.2024.1396996.

    PMID: 38756750
  10. 10

    Ultrastructural deposits appearing as "zebra bodies" in renal biopsy: Fabry disease?- comparative case reports.

    de Menezes Neves PDM, Machado JR, Custódio FB, et al.

    BMC nephrology 2017; (18(1)):157 doi:10.1186/s12882-017-0571-0.

    PMID: 28499424
  11. 11

    Angiokeratomas, not everything is Fabry disease.

    Cuestas D, Perafan A, Forero Y, et al.

    International journal of dermatology 2019; (58(6)):713-721 doi:10.1111/ijd.14330.

    PMID: 30656678
  12. 12

    Late-Onset Fabry Disease Affecting the Kidneys and Liver While Sparing the Heart: A Case Report.

    Alitter Q

    Cureus 2022; (14(11)):e30989 doi:10.7759/cureus.30989.

    PMID: 36475199
  13. 13

    Of the importance of the clinical phenotypes in the interpretation of the studies dealing with Fabry disease.

    Mauhin W, Lidove O, Benveniste O

    Orphanet journal of rare diseases 2019; (14(1)):4 doi:10.1186/s13023-018-0979-z.

    PMID: 30616652
  14. 14

    Cardiac magnetic resonance diagnosis of Fabry disease leads to incidental diagnosis of Klinefelter syndrome: a case report.

    Binda G, Bridgman JC, Chapman I, Selvanayagam JB

    European heart journal. Case reports 2022; (6(9)):ytac328 doi:10.1093/ehjcr/ytac328.

    PMID: 36131908
  15. 15

    High Prevalence of Late-Onset Fabry Cardiomyopathy in a Cohort of 499 Non-Selective Patients with Left Ventricular Hypertrophy: The Asian Fabry Cardiomyopathy High-Risk Screening Study (ASIAN-FAME).

    Fan Y, Chan TN, Chow JTY, et al.

    Journal of clinical medicine 2021; (10(10)) doi:10.3390/jcm10102160.

    PMID: 34067605
  16. 16

    Late-onset fabry disease presenting with unexplained renal failure, left ventricular hypertrophy, and recurrent syncope: a case report.

    Ying Q, Yang X, Zhao N, et al.

    Orphanet journal of rare diseases 2025; (20(1)):271 doi:10.1186/s13023-025-03791-4.

    PMID: 40462218
  17. 17

    Relapsing minimal change disease superimposed on late-onset p.N215S Fabry nephropathy.

    Salerno FR, Roggero L, Rossi F, et al.

    Clinical kidney journal 2022; (15(1)):171-173 doi:10.1093/ckj/sfab148.

    PMID: 35035949
  18. 18

    The Prevalence and Clinical Features of Fabry Disease in Hemodialysis Patients: Russian Nationwide Fabry Dialysis Screening Program.

    Moiseev S, Fomin V, Savostyanov K, et al.

    Nephron 2019; (141(4)):249-255 doi:10.1159/000495886.

    PMID: 30677769
  19. 19

    Different renal phenotypes in related adult males with Fabry disease with the same classic genotype.

    Mignani R, Moschella M, Cenacchi G, et al.

    Molecular genetics & genomic medicine 2017; (5(4)):438-442 doi:10.1002/mgg3.292.

    PMID: 28717668
  20. 20

    Identification of Four New Mutations in the GLA Gene Associated with Anderson-Fabry Disease.

    Anania M, Pieruzzi F, Giacalone I, et al.

    International journal of molecular sciences 2025; (26(2)) doi:10.3390/ijms26020473.

    PMID: 39859188
  21. 21

    [The neurological manifestations of Fabry disease. A review].

    Firsov KV, Kotov AS

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2016; (116(9)):98-105 doi:10.17116/jnevro20161169198-105.

    PMID: 27735906
  22. 22

    Fabry disease in cardiology practice: Literature review and expert point of view.

    Hagège A, Réant P, Habib G, et al.

    Archives of cardiovascular diseases 2019; (112(4)):278-287 doi:10.1016/j.acvd.2019.01.002.

    PMID: 30826269
  23. 23

    [Heart involvement in Anderson-Fabry disease: Italian recommendations for diagnostic, follow-up and therapeutic management].

    Pieruzzi F, Pieroni M, Zachara E, et al.

    Giornale italiano di cardiologia (2006) 2015; (16(11)):630-8 doi:10.1714/2066.22434.

    PMID: 26571477
  24. 24

    Multiple sclerosis and fabry Disease, two sides of the coin? The case of an Italian family.

    Russo C, Riccio E, Pontillo G, et al.

    Multiple sclerosis and related disorders 2018; (26()):164-167 doi:10.1016/j.msard.2018.09.019.

    PMID: 30268036
  25. 25

    Induced pluripotent stem cell line (INSAi002-A) from a Fabry Disease patient hemizygote for the rare p.W287X mutation.

    Duarte AJ, Ribeiro D, Santos R, et al.

    Stem cell research 2020; (45()):101794 doi:10.1016/j.scr.2020.101794.

    PMID: 32388441
  26. 26

    Correlation of X chromosome inactivation with clinical presentation of Fabry disease in a case report.

    Rodríguez Doyágüez P, Furlano M, Ars Criach E, et al.

    Nefrologia 2023; (43 Suppl 2()):91-95 doi:10.1016/j.nefroe.2024.01.018.

    PMID: 38278716
  27. 27

    Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease.

    Tuttolomondo A, Simonetta I, Duro G, et al.

    Oncotarget 2017; (8(37)):61415-61424 doi:10.18632/oncotarget.18250.

    PMID: 28977874

This page is for informational purposes only and does not replace professional medical advice. If you suspect you or your child has symptoms of Fabry disease, consult your healthcare provider or a genetic specialist.

Stay up to date

Get notified when new research about Fabry disease is published.

No spam. Unsubscribe anytime.